Vyome Holdings, Inc. (HIND)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.09M
Last updated: Nov 17, 2026 at 11:02 AM ET
Vyome Holdings, Inc. (HIND) Competitors
The companies most similar to Vyome Holdings are Biovie (BIVI), Vyne Therapeutics (VYNE) and Longeveron LLC (LGVN). By market cap, Vyome Holdings ranks 5th of the 13 companies on this page; Vyne Therapeutics (VYNE) is the largest at $19.07M.
Peer Comparison
HIND's revenue growth of 67.5% is above the peer median of -4.6%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Vyome Holdings (HIND) | $11.09M | N/A | N/A | 0.0% | N/A | 67.5% | 0.00% |
| Biovie Inc (BIVI) | $12.12M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vyne Therapeutics Inc (VYNE) | $19.07M | N/A | N/A | 0.0% | N/A | -57.4% | 0.00% |
| Longeveron LLC (LGVN) | $8.40M | N/A | 5.9x | 0.0% | N/A | -9.2% | 0.00% |
| Moleculin Biotech Inc (MBRX) | $8.02M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Soligenix Inc. (SNGX) | $7.50M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Chemomab Therapeutics Ltd DRC (CMMB) | $12.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | $9.90M | N/A | 16.4x | 0.0% | -72.3% | -15.9% | 0.00% |
| Immuron Ltd ADR (IMRN) | $7.06M | N/A | 0.9x | -47.7% | N/A | 7.2% | 0.00% |
| VistaGen Therapeutics Inc (VTGN) | $8.01M | N/A | 3.4x | 0.0% | N/A | -46.5% | 0.00% |
| Phio Pharmaceuticals Corp (PHIO) | $9.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Theriva Biologics Inc. (TOVX) | $6.61M | N/A | 21.5x | 0.0% | -52.3% | 0.0% | 0.00% |
| Marker Therapeutics Inc (MRKR) | $14.51M | N/A | 14.5x | -245.5% | N/A | -51.0% | 0.00% |
| Peer median | $8.81M | N/A | 10.2x | 0.0% | -62.3% | -4.6% | 0.00% |
Similar Companies
These are the 12 companies most similar to Vyome Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Biovie Inc (BIVI) | BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. | BIVI competitors |
| Vyne Therapeutics Inc (VYNE) | VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. | |
| Longeveron LLC (LGVN) | Longeveron Inc., a clinical-stage biotechnology company, is dedicated to developing cell therapies for life-threatening and aging-related conditions. | LGVN competitors |
| Moleculin Biotech Inc (MBRX) | Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant... | MBRX competitors |
| Soligenix Inc. (SNGX) | Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. | SNGX competitors |
| Chemomab Therapeutics Ltd DRC (CMMB) | Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. | CMMB competitors |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human... | |
| Immuron Ltd ADR (IMRN) | Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious... | |
| VistaGen Therapeutics Inc (VTGN) | VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential... | VTGN competitors |
| Phio Pharmaceuticals Corp (PHIO) | Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts. | PHIO competitors |
| Theriva Biologics Inc. (TOVX) | Theriva Biologics Inc., a clinical-stage company, develops therapies to treat diseases in areas of high unmet need. | TOVX competitors |
| Marker Therapeutics Inc (MRKR) | Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based... | MRKR competitors |
Frequently Asked Questions About HIND
Who are Vyome Holdings' main competitors?
The companies most similar to Vyome Holdings include Biovie (BIVI), Vyne Therapeutics (VYNE), Longeveron LLC (LGVN), Moleculin Biotech (MBRX) and Soligenix (SNGX), listed from the closest match.
Who is Vyome Holdings' biggest competitor?
Vyne Therapeutics (VYNE) is the largest of the similar companies at $19.07M; Biovie (BIVI) is the closest match by business profile, size, sector and industry.
How does HIND stock compare with its competitors?
HIND's net margin is 0.0% against a peer median of 0.0%.
Which of Vyome Holdings' competitors pays a higher dividend?
Vyome Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Vyome Holdings bigger than its competitors?
No. Vyome Holdings is 5th by market cap among the 13 companies on this page; the largest is Vyne Therapeutics (VYNE) at $19.07M.
HIND pages: Overview, Earnings, Forecast, Financials, Competitors